REFERENCES
- Goldspiel B.R., Kholer D.R. Flutamide: An Antiandrogen for Advanced Prostate Cancer. Drug Intelligence and Clinical Pharmacy, 1990; 24: 616–623
- Schulz M., Schmoldt A., Donn F., Becker H. The Pharmacokinetics of Flutamide and Its Major Metabolites After a Single Oral Dose and During Chronic Treatment. Eur. J. Clin. Pharmacol. 1988; 34: 633–636
- Brogden R.N., Clissod S.P. Flutamide. A Preliminary Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Advanced Prostatic Cancer. Drugs 1989; 38: 185–203
- Aso Y., Akaza H., Koiso K., Kumamoto Y., Kawai T., Origasa S., Hosaka M., Yamanaka H., Shimazaki J., Fuse H. Phase I Study of Flutamide, a Nonsteroidal Antiandrogen, in Patients with Prostatic Cancer. Hinyokika Kiyo 1993; 39: 381–389
- Brogden R.N., Chrisp P. Flutamide. A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Advanced Prostatic Cancer. Drugs Aging 1991; 1: 104–115
- Chabner B.A., Allegra C.J., Curt C.A., Calabresi P. Fármacos Antineoplásicos. Las Bases Farmacológicas de la Terapéutica, 9th Ed., A. Goodman, J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon. McGraw-Hill Interamericana, Mexico 1996; 1309–1367
- Caraballo I., Millán M. Percolation Thresholds in Ultrasound Compacted Tablets. J. Contr. Rel. 2000; 69: 345–355
- Caraballo I., Fernández-Arévalo M., Holgado M.A., Vela M.T., Rabasco A.M. A Rapid HPLC Method for the Quantification of Tyrotrhicin, Menthol and Benzocaine in Pharmaceutical Formulations. J. Pharm. Sci. 1994; 83: 1147–1149
- U.S. Pharmacopeia. U.S. Pharmacopeial Convention. Rockville, MD 1995; 2053